Li Cao

674 total citations
27 papers, 539 citations indexed

About

Li Cao is a scholar working on Rheumatology, Molecular Biology and Pharmacology. According to data from OpenAlex, Li Cao has authored 27 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 10 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Li Cao's work include Osteoarthritis Treatment and Mechanisms (11 papers), Inflammatory mediators and NSAID effects (6 papers) and Chemokine receptors and signaling (4 papers). Li Cao is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (11 papers), Inflammatory mediators and NSAID effects (6 papers) and Chemokine receptors and signaling (4 papers). Li Cao collaborates with scholars based in China and United States. Li Cao's co-authors include Daolin Tang, Yan Yu, Lei Yang, Ming Zhao, Philip Vernon, R Kang, Shan Zhu, Baochao Ji, Wenbo Mu and Boyong Xu and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Li Cao

25 papers receiving 533 citations

Peers

Li Cao
Jen‐Tsun Lin Taiwan
Weigan Shen China
Zhongjie Yi China
Palani Dinesh India
Jun Bao China
Michele L. Kus United Kingdom
Tingwang Jiang China
Xiaoying Zhao China
Kang Zheng China
Jen‐Tsun Lin Taiwan
Li Cao
Citations per year, relative to Li Cao Li Cao (= 1×) peers Jen‐Tsun Lin

Countries citing papers authored by Li Cao

Since Specialization
Citations

This map shows the geographic impact of Li Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Cao more than expected).

Fields of papers citing papers by Li Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Cao. The network helps show where Li Cao may publish in the future.

Co-authorship network of co-authors of Li Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Li Cao. A scholar is included among the top collaborators of Li Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Cao. Li Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Liang, Yun Zheng, Li Cao, et al.. (2025). Tumor‐Adhesive Chitosan‐Derived Multi‐Immune Agonist Unleashes Strong and Durable Anti‐Cancer Immunity. Advanced Science. 12(16). e2414110–e2414110. 3 indexed citations
2.
3.
Cao, Li, Ke Jia, Brian A. Van Tine, et al.. (2025). KPNA2 promotes osteosarcoma progression by regulating the alternative splicing of DDX3X mediated by YBX1. Oncogene. 44(26). 2186–2200. 1 indexed citations
4.
Cao, Jun, Miao Sun, Liang Yang, et al.. (2025). Sustained codelivery of heat shock protein peptide and rapamycin via nano-in-hydrogel induces immune tolerance in rheumatoid arthritis. Journal of Controlled Release. 383. 113842–113842. 1 indexed citations
5.
6.
7.
Zhang, Xiaoyan, Chenxi Sun, Jinfang Hao, et al.. (2023). Metformin inhibits EV71‑induced pyroptosis by upregulating DEP domain‑containing mTOR‑interacting protein. Experimental and Therapeutic Medicine. 26(2). 388–388. 1 indexed citations
8.
Cao, Li, et al.. (2022). Oxymatrine Protects Chondrocytes against IL-1β-triggered Apoptosis in Vitro and Inhibits Osteoarthritis in Mice Model. Evidence-based Complementary and Alternative Medicine. 2022. 1–10. 4 indexed citations
9.
10.
Li, Yicheng, Wenbo Mu, Boyong Xu, et al.. (2019). Artesunate, an Anti-Malaria Agent, Attenuates Experimental Osteoarthritis by Inhibiting Bone Resorption and CD31hiEmcnhi Vessel Formation in Subchondral Bone. Frontiers in Pharmacology. 10. 685–685. 30 indexed citations
11.
Tu, Manli, Mi Yang, Gehua Zhen, et al.. (2019). Inhibition of cyclooxygenase-2 activity in subchondral bone modifies a subtype of osteoarthritis. Bone Research. 7(1). 29–29. 54 indexed citations
12.
Mu, Wenbo, Boyong Xu, Jiao Li, et al.. (2018). Halofuginone Attenuates Osteoarthritis by Rescuing Bone Remodeling in Subchondral Bone Through Oral Gavage. Frontiers in Pharmacology. 9. 269–269. 17 indexed citations
13.
Ji, Baochao, Zhendong Zhang, Wentao Guo, et al.. (2018). Isoliquiritigenin blunts osteoarthritis by inhibition of bone resorption and angiogenesis in subchondral bone. Scientific Reports. 8(1). 1721–1721. 36 indexed citations
14.
15.
Wang, Yang, et al.. (2018). Protective effects of gemigliptin against type II collagen degradation in human chondrocytes. Biomedicine & Pharmacotherapy. 104. 590–594. 11 indexed citations
16.
Mu, Wenbo, Boyong Xu, Baochao Ji, et al.. (2017). Halofuginone attenuates articular cartilage degeneration by inhibition of elevated TGF-β1 signaling in articular cartilage in a rodent osteoarthritis model. Molecular Medicine Reports. 16(5). 7679–7684. 9 indexed citations
17.
Cao, Li, et al.. (2015). Potential role of heat-shock proteins in giant cell tumors. Genetics and Molecular Research. 14(4). 19144–19154. 2 indexed citations
18.
19.
Yu, Yan, Lei Yang, Ming Zhao, et al.. (2012). Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells. Leukemia. 26(8). 1752–1760. 172 indexed citations
20.
Cao, Li, et al.. (2010). No Clear Advantage to Use of Wound Drains After Unilateral Total Knee Arthroplasty. The Journal of Arthroplasty. 26(4). 519–522. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jen‐Tsun Lin Breakdown of academic impact, for papers by Weigan Shen Breakdown of academic impact, for papers by Zhongjie Yi Breakdown of academic impact, for papers by Palani Dinesh Breakdown of academic impact, for papers by Jun Bao Breakdown of academic impact, for papers by Michele L. Kus Breakdown of academic impact, for papers by Tingwang Jiang Breakdown of academic impact, for papers by Xiaoying Zhao Breakdown of academic impact, for papers by Kang Zheng
Rankless by CCL
2026